Clinical isolate of Pseudomonas aeruginosa that degrades salicylate by the ortho pathway.
A clinical isolate of Pseudomonas aeruginosa was found capable of utilizing salicylate by the salicylate hydroxylase and beta-ketoadipate pathway.
D001565:Benzoates / Q000378:metabolism; D050548:Catechol 1,2-Dioxygenase; D050557:Catechol 2,3-Dioxygenase; D049308:Dioxygenases; D006899:Mixed Function Oxygenases / Q000378:metabolism; D010105:Oxygenases / Q000378:metabolism; D011550:Pseudomonas aeruginosa / Q000378:metabolism*; D012459:Salicylates / Q000378:metabolism*
D001565:Benzoates; D012459:Salicylates; D006899:Mixed Function Oxygenases; D010105:Oxygenases; D049308:Dioxygenases; D050548:Catechol 1,2-Dioxygenase; D050557:Catechol 2,3-Dioxygenase; C022619:salicylate 1-monooxygenase